Anti-PI 3 Kinase catalytic subunit alpha antibody [EP383Y]

Name Anti-PI 3 Kinase catalytic subunit alpha antibody [EP383Y]
Supplier Abcam
Catalog ab40776
Prices $99.00, $384.00
Sizes 10 µl, 100 µl
Host Rabbit
Clonality Monoclonal
Isotype IgG
Clone EP383Y
Applications WB ICC/IF ICC/IF IP
Species Reactivities Human
Antigen Synthetic peptide of human near the C-terminal of P13-K p110 alpha
Description Rabbit Monoclonal
Gene PIK3CA
Conjugate Unconjugated
Supplier Page Shop

Product images


Product References

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the - A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the

Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. Clin Proteomics. 2010 Dec;6(4):129-51.

Different changes in protein and phosphoprotein levels result from serum - Different changes in protein and phosphoprotein levels result from serum

Levin VA, Panchabhai SC, Shen L, Kornblau SM, Qiu Y, Baggerly KA. J Proteome Res. 2010 Jan;9(1):179-91.

Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K - Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K

Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S. Cancer Cell. 2009 Dec 8;16(6):463-74.

Combined Src and aromatase inhibition impairs human breast cancer growth in vivo - Combined Src and aromatase inhibition impairs human breast cancer growth in vivo

Chen Y, Guggisberg N, Jorda M, Gonzalez-Angulo A, Hennessy B, Mills GB, Tan CK, Slingerland JM. Clin Cancer Res. 2009 May 15;15(10):3396-405.

A novel derivative of the natural agent deguelin for cancer chemoprevention and - A novel derivative of the natural agent deguelin for cancer chemoprevention and

Kim WY, Chang DJ, Hennessy B, Kang HJ, Yoo J, Han SH, Kim YS, Park HJ, Seo SY, Mills G, Kim KW, Hong WK, Suh YG, Lee HY. Cancer Prev Res (Phila). 2008 Dec;1(7):577-87. doi: